Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Mylan and Aspen Announce Launch of Generic Busulfex® Injection

      Americas
      Mylan N.V. and its partner, Aspen announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version...

      Triphase Accelerator To Present Investigational New Drug Enabling Data For TRPH-222

      Americas
      Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider of...

      EMA accepts marketing application for trastuzumab and pegfilgrastim

      Europe
      The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim. The proposed biosimilars...

      Merck to present new and updated data of Keytruda to treat breast cancers at 2017 SABC symposium

      Europe
      Merck, known as MSD outside the United States and Canada, announced that new and updated data from six abstracts investigating Keytruda (pembrolizumab), the company’s...

      Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting

      Americas
      Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a clinical-stage biopharmaceutical company, today announced the presentation of a scientific poster entitled “Selective Inhibitors Suggest Nav1.6 Activity is the...

      FDA Approves Amgen’s Repatha® (evolocumab) To Prevent Heart Attack And Stroke

      FDA Approvals
      Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha® (evolocumab) as the...

      NIH initiates HIV prevention trial of long-acting injectable medication in sexually active women

      Americas
      The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study in southern and...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.